Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NRXS

Neuraxis Inc

6.87

Aug 10 • 3:59 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Micro AMEX

Today, 4:00 AMNeuraxis Inc is scheduled to announce earnings today before market open

Peers: ANIX ATYR COYA CYPH INO LONA CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC BUSM

Scroll to Statements

Index	-
Market Cap	85.72M
Enterprise Value	78.99M
Income	-8.07M
Sales	4.28M
Book/sh	0.50
Cash/sh	0.57
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	24
IPO	Aug 09, 2023

P/E	-
Forward P/E	-
PEG	-
P/S	20.03
P/B	13.70
P/C	12.11
P/FCF	-
EV/EBITDA	-
EV/Sales	18.46
Quick Ratio	2.81
Current Ratio	2.89
Debt/Eq	0.06
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-0.81
EPS next Y	-0.06
EPS next Q	-0.32
EPS this Y	28.42%
EPS next Y	91.18%
EPS next 5Y	-
EPS past 3/5Y	-1.64% -6.18%
Sales past 3/5Y	9.96% 13.08%
EPS Y/Y TTM	34.17%
Sales Y/Y TTM	45.88%
EPS Q/Q	46.63%
Sales Q/Q	79.52%
Earnings	Aug 11 BMO
EPS/Sales Surpr.	5.26% 10.89%

Insider Own	26.01%
Insider Trans	3.06%
Inst Own	20.13%
Inst Trans	11.19%
ROA	-123.70%
ROE	-242.53%
ROIC	-122.79%
Gross Margin	85.00%
Oper. Margin	-169.93%
Profit Margin	-188.57%
SMA20	1.53%
SMA50	-0.67%
SMA200	21.93%
Trades

Shs Outstand	11.45M
Shs Float	9.17M
Short Float	5.14%
Short Ratio	4.59
Short Interest	0.47M
52W High	9.33 -26.37%
52W Low	2.20 212.80%
Volatility	5.51% 5.75%
ATR (14)	0.39
RSI (14)	50.69
Beta	1.49
Rel Volume	0.00
Avg Volume	102.60K
Volume	0

Perf Week	4.25%
Perf Month	-3.78%
Perf Quarter	-16.22%
Perf Half Y	57.93%
Perf YTD	51.32%
Perf Year	179.27%
Perf 3Y	13.18%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	11.00
Prev Close	6.87
Price	6.87
Change %	0.00%

Aug-10-26 09:25AM	Earnings To Watch: Neuraxis Inc (NRXS) Q2 2026 -- GF Value Sees 55% Downside (GuruFocus.com)
Aug-04-26 07:00AM	NeurAxis Expands Payer Coverage with New Policies (GlobeNewswire) +6.37%
Jul-28-26 07:00AM	NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026 (GlobeNewswire)
May-13-26 08:30AM	NeurAxis, Inc. Q1 2026 Earnings Call Summary (Moby)
May-12-26 07:01PM	Neuraxis Inc (NRXS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amid Coverage Challenges (GuruFocus.com)
07:05AM	Loading…
07:05AM	NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth (GlobeNewswire)
May-11-26 09:23AM	Earnings To Watch: Neuraxis Inc (NRXS) Reports Q1 2026 Result (GuruFocus.com)
May-05-26 07:00AM	NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 (GlobeNewswire)
Apr-22-26 07:00AM	NeurAxis Expands Payer Coverage with Four New Medical Policies (GlobeNewswire)
Apr-10-26 07:00AM	NeurAxis, Inc. Announces Preferred Stock Dividend (GlobeNewswire) -5.66%
Mar-19-26 03:02PM	Neuraxis Inc (NRXS) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Operational Challenges (GuruFocus.com)
08:30AM	NeurAxis, Inc. Q4 2025 Earnings Call Summary (Moby)
07:05AM	NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-12-26 09:00AM	NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026 (GlobeNewswire)
Jan-08-26 08:00AM	NeurAxis Achieves Major Milestone with AMA Category I CPT Code Now in Effect, Establishing a Permanent Reimbursement Pathway (GlobeNewswire)
04:41AM	Loading…
Jan-06-26 04:41AM	The Zacks Analyst Blog Meta, Bank of America, The Procter & Gamble, Espey and NeurAxis (Zacks)
Jan-05-26 04:34PM	Top Stock Reports for Meta, Bank of America & Procter & Gamble (Zacks)
Dec-19-25 08:00AM	NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives (GlobeNewswire) +11.81%
Dec-01-25 07:00AM	NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain (GlobeNewswire)
Nov-17-25 12:17PM	NRXS Stock Declines Post Q3 Earnings Despite Continued Revenue Growth (Zacks)
Nov-12-25 08:00AM	NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives (GlobeNewswire) +7.88%
Nov-11-25 07:00AM	NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues (GlobeNewswire) -5.86%
Nov-04-25 08:30AM	NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025 (GlobeNewswire) -5.22%
Oct-24-25 08:00AM	NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population (GlobeNewswire) -8.64%
Sep-18-25 08:00AM	NeurAxis to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025 (GlobeNewswire)
Sep-17-25 05:53AM	The Zacks Analyst Blog Highlights Alphabet, IBM, Merck, SandRidge Energy and NeurAxis (Zacks) +5.35%
Sep-16-25 04:42PM	Top Research Reports for Alphabet, IBM & Merck (Zacks)
Aug-18-25 02:27PM	NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth (Zacks)
Aug-12-25 07:00AM	NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues (GlobeNewswire)
Aug-05-25 08:30AM	NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025 (GlobeNewswire)
04:53AM	Loading…
Jun-27-25 04:53AM	The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis (Zacks)
Jun-26-25 04:34PM	Top Stock Reports for Microsoft, NVIDIA & Bank of America (Zacks)
Jun-17-25 08:00AM	NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives (GlobeNewswire)
Jun-10-25 08:00AM	NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS (GlobeNewswire) -8.65%
May-27-25 08:00AM	NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025 (GlobeNewswire)
May-22-25 01:03PM	NeurAxis Announces Closing of $5.0 Million Registered Direct Offering (GlobeNewswire) -5.31%
May-21-25 07:00AM	NeurAxis Announces $5.0 Million Registered Direct Offering (GlobeNewswire) -19.80%
May-20-25 08:00AM	NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pediatric FAP/Functional Dyspepsia (FD) and Associated Nausea Symptoms (GlobeNewswire) +75.77%
May-15-25 12:06PM	NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones (Zacks)
May-12-25 08:15AM	NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues (GlobeNewswire) +16.00%
May-05-25 09:00AM	NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025 (GlobeNewswire) -11.64%
May-01-25 04:49AM	The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis (Zacks)
Apr-30-25 05:02PM	Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems (Zacks) +5.86%
Apr-15-25 09:00AM	NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 (GlobeNewswire)
Mar-24-25 11:20AM	NeurAxis Stock Gains Post Q4 Earnings and Revenue Growth (Zacks) -6.06%
Mar-20-25 04:18PM	NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript (SeekingAlpha)
08:15AM	NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues (GlobeNewswire)
Mar-12-25 09:00AM	NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025 (GlobeNewswire)
Jan-21-25 01:45PM	UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States (GlobeNewswire)
09:00AM	NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States (GlobeNewswire)
Jan-13-25 09:00AM	NeurAxis Inc. Issues Letter to Shareholders (GlobeNewswire)
Jan-08-25 09:00AM	NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year (GlobeNewswire)
Jan-06-25 09:00AM	NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 (GlobeNewswire) +11.57%
Dec-10-24 09:00AM	NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation (GlobeNewswire) -7.48%
Nov-12-24 08:10AM	NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues (GlobeNewswire) +26.40%
Nov-05-24 09:00AM	NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024 (GlobeNewswire)
Nov-04-24 09:00AM	NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market (GlobeNewswire)
Oct-29-24 09:00AM	NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 (GlobeNewswire)
Oct-22-24 09:00AM	NeurAxis Announces New CPT Category I Code for Percutaneous Electrical Nerve Field Stimulation (GlobeNewswire) +5.07%
Sep-19-24 09:00AM	NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 (GlobeNewswire)
Aug-27-24 09:00AM	NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 (GlobeNewswire)
Aug-13-24 09:00AM	NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 (GlobeNewswire)
Aug-09-24 08:00AM	NeurAxis Reports Second Quarter 2024 Financial Results (GlobeNewswire) +9.12%
Aug-05-24 09:00AM	NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 (GlobeNewswire) -17.61%
Jun-07-24 09:00AM	NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure (GlobeNewswire)
May-22-24 08:00AM	NeurAxis Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-21-24 09:00AM	NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 (GlobeNewswire)
May-16-24 09:00AM	NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in Florida (GlobeNewswire) +11.96%
May-15-24 04:30PM	NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024 (GlobeNewswire)
Apr-23-24 09:00AM	NeurAxis Announces New Medical Policy Coverage in North Dakota (GlobeNewswire) -11.18%
Apr-12-24 08:44AM	NeurAxis, Inc. (NASDAQ:NRXS) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-09-24 04:05PM	NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
Apr-01-24 04:15PM	NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024 (GlobeNewswire)
Mar-27-24 09:00AM	NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry (GlobeNewswire)
Mar-11-24 09:00AM	NeurAxis Announces Highmark BCBS Policy Coverage (GlobeNewswire)
Mar-04-24 09:00AM	NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage (GlobeNewswire) +8.82%
Feb-27-24 11:00AM	NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Jan-31-24 09:00AM	NeurAxis Appoints Timothy Henrichs as Chief Financial Officer (GlobeNewswire)
Dec-20-23 09:00AM	NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer (GlobeNewswire)
Nov-20-23 05:30PM	NeurAxis Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-15-23 09:00AM	NeurAxis Announces CareFirst BCBS Policy Coverage (GlobeNewswire) +14.17%
Nov-14-23 09:00AM	NeurAxis Secures $3 Million Financing (GlobeNewswire)
Nov-08-23 09:00AM	NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device (GlobeNewswire)
Sep-26-23 09:00AM	NeurAxis Announces Results of Comparative Study of IB-Stim and Standard Medical Therapy in Adolescents with Functional Abdominal Pain Disorders (GlobeNewswire)
Sep-21-23 08:00AM	NeurAxis Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Sep-13-23 09:00AM	NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase (GlobeNewswire) +7.87%
Sep-12-23 10:15AM	EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome (Benzinga) -16.92%
09:00AM	NeurAxis Announces Publication of Prospective Study Showing IB-Stim Improves Quality of Life of Adolescents with IBS (GlobeNewswire)
Aug-29-23 09:00AM	NeurAxis Highlights Pediatric Post-Concussion Clinical Study (GlobeNewswire)
Aug-24-23 09:00AM	NeurAxis Highlights Strength of its Board of Directors (GlobeNewswire) -10.15%
Aug-22-23 09:00AM	NeurAxis Highlights Two Independent Studies Showing Benefits of IB-Stim in Adolescents Involving the Gut Microbiome (GlobeNewswire) +16.50%
Aug-17-23 09:02AM	NeurAxis Announces Over $8 Million in IB-Stim Revenue (GlobeNewswire)
Aug-15-23 09:00AM	NeurAxis Announces Positive University of Michigan IB-Stim Cost Effectiveness Study at ANMS 2023 (GlobeNewswire)
Aug-11-23 09:30AM	Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc. (ACCESSWIRE)
Aug-10-23 09:00AM	NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin (GlobeNewswire)
09:00AM	Exchange Listing Client, Neuraxis, Inc., Successfully Completes Its Initial Public Offering and NYSE Listing (GlobeNewswire)
Aug-09-23 10:00AM	NeurAxis Announces Pricing of Initial Public Offering (GlobeNewswire)

NeurAxis, Inc. engages in the provision of neuromodulation therapies to address chronic and debilitating conditions in children. Its product, IB-Stim, is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear. The company was founded by Gary Peterson and Christopher Robin Brown in 2011 and is headquartered in Carmel, IN.

PresidentMr. Brian Carrico

Chief Financial OfficerMr. Timothy Robert Henrichs

Senior VP of Science & Technology and Chief Medical OfficerDr. Adrian Miranda

FounderDr. Christopher Robin Brown D.D.S.

Vice President of SalesRyan Kuhlman

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Henrichs Timothy Robert	Chief Financial Officer	Apr 01 '26	Buy	1.96	7,593	14,882	7,593	Apr 03 11:23 AM
Carrico Thomas Joeseph	CRO, CCO, CPO	Apr 01 '26	Buy	1.96	667	1,307	331,903	Apr 03 11:21 AM
Carrico Brian Allen	Chief Executive Officer	Apr 01 '26	Buy	1.96	8,060	15,798	348,178	Apr 03 11:19 AM
Hannasch Brian	10% Owner	Feb 12 '26	Buy	4.92	40,000	196,800	1,211,522	Feb 13 04:04 PM
Hannasch Brian	10% Owner	Feb 11 '26	Buy	4.65	40,000	186,000	1,171,522	Feb 13 04:04 PM
Aharon Gil	Director	Dec 23 '25	Buy	3.52	286,138	1,007,206	286,138	Dec 29 05:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NRXS

Neuraxis Inc

Upgrade your Finviz experience